These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 17999022

  • 1. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.
    Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY.
    Osteoporos Int; 2008 Jun; 19(6):811-8. PubMed ID: 17999022
    [Abstract] [Full Text] [Related]

  • 2. Low incidence of anti-osteoporosis treatment after hip fracture.
    Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY.
    J Bone Joint Surg Am; 2008 Oct; 90(10):2142-8. PubMed ID: 18829912
    [Abstract] [Full Text] [Related]

  • 3. Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday.
    Curtis JR, Westfall AO, Cheng H, Delzell E, Saag KG.
    Osteoporos Int; 2008 Nov; 19(11):1613-20. PubMed ID: 18483689
    [Abstract] [Full Text] [Related]

  • 4. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.
    Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S.
    Mayo Clin Proc; 2006 Aug; 81(8):1013-22. PubMed ID: 16901023
    [Abstract] [Full Text] [Related]

  • 5. Adherence to osteoporosis medications amongst Singaporean patients.
    Cheen MH, Kong MC, Zhang RF, Tee FM, Chandran M.
    Osteoporos Int; 2012 Mar; 23(3):1053-60. PubMed ID: 21503813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.
    Cotté FE, Fardellone P, Mercier F, Gaudin AF, Roux C.
    Osteoporos Int; 2010 Jan; 21(1):145-55. PubMed ID: 19459025
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.
    Olsen KR, Hansen C, Abrahamsen B.
    Osteoporos Int; 2013 Oct; 24(10):2639-47. PubMed ID: 23604250
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy.
    Lindsay R, Watts NB, Lange JL, Delmas PD, Silverman SL.
    Osteoporos Int; 2013 Aug; 24(8):2345-52. PubMed ID: 23612793
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.
    Lee S, Glendenning P, Inderjeeth CA.
    Osteoporos Int; 2011 Mar; 22(3):741-53. PubMed ID: 20589368
    [Abstract] [Full Text] [Related]

  • 13. The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.
    Rietbrock S, Olson M, van Staa TP.
    QJM; 2009 Jan; 102(1):35-42. PubMed ID: 18842684
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis.
    Imaz I, Zegarra P, González-Enríquez J, Rubio B, Alcazar R, Amate JM.
    Osteoporos Int; 2010 Nov; 21(11):1943-51. PubMed ID: 19967338
    [Abstract] [Full Text] [Related]

  • 17. Alendronate adherence and its impact on hip-fracture risk in patients with established osteoporosis in Taiwan.
    Lin TC, Yang CY, Yang YH, Lin SJ.
    Clin Pharmacol Ther; 2011 Jul; 90(1):109-16. PubMed ID: 21525868
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hip fractures in users of first- vs. second-generation bisphosphonates.
    Mamdani M, Kopp A, Hawker G.
    Osteoporos Int; 2007 Dec; 18(12):1595-600. PubMed ID: 17767369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.